Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Improved MPPC for General Photon Counting Applications

Published: Tuesday, October 08, 2013
Last Updated: Monday, October 07, 2013
Bookmark and Share
Hamamatsu introduces new S12571 series of multi-pixel photon counter devices.

Hamamatsu Photonics have expanded and improved on their range of semi-conductor detectors, featuring photon counting capability, with the introduction of the brand new S12571 series of multi-pixel photon counter devices (MPPC).

This new series of general purpose MPPC offers drastically reduced afterpulsing compared to previous Hamamatsu MPPC detectors.

The S12571 series are 1x1mm devices supplied in ultra-compact surface mount plastic packages, or through-hole ceramic packages.

Various pixel configurations are available, with pitches of 25um, 50um and 100um and pixel numbers of 1,600, 400 and 100 respectively.

Each pixel contains a quenching resistor so that simultaneous photon events can be counted separately and with a high degree of accuracy.

The devices feature typical high gain values of 5.15E5 to 2.8E6, comparable to that achievable from a conventional photomultiplier tube.

Some other key areas of improvement to the MPPC include; greatly reduced dark count, reduced afterpulsing, increased photon detection efficiency, improvements in timing resolution and linearity as well as reduced crosstalk.

The result of these and other improvements means that the MPPC now has a much improved signal-to-noise ratio, wider operating voltage range, improved time resolution and a wider dynamic range.

With these improvements, the S12571 series are ideal for a variety of applications, including positron emission tomography, high-energy physics, DNA sequencing, fluorescence measurement, nuclear medicine, point of care systems, drug discovery, medical diagnostic equipment and environmental analysis.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Biomarker Finder Adjusts On the Fly
Rice University scientists build better tool to find signs of disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos